Thanks for the nice summary Nava, very informative, especially the video. Does seem like a very hard scaling problem. Naive question: would the harsh treatments of Edman degradation cause single molecule sensitivity to be lost?
Regarding potential market size (IF technical hurdles are overcome) wouldn’t you expect NGPS to take over from Olink/Somalogic/Nomic etc? Given that Thermo paid 3B for Olink, presumably NGPS would command similar or greater numbers?
Thanks for the nice summary Nava, very informative, especially the video. Does seem like a very hard scaling problem. Naive question: would the harsh treatments of Edman degradation cause single molecule sensitivity to be lost?
Regarding potential market size (IF technical hurdles are overcome) wouldn’t you expect NGPS to take over from Olink/Somalogic/Nomic etc? Given that Thermo paid 3B for Olink, presumably NGPS would command similar or greater numbers?
it's Raman, unless you're measuring noodles
Ahhh... every time! Fixed, thanks!